As Managing Partner of 5AM Ventures, Dr. Scott M. Rocklage, Ph.D has a variety of responsibilities. Not only does he study new areas of life sciences, he also works with the company’s management team and attends board meetings. He works with scientists, physicians and business executives to turn ideas into treatments to meet medical needs. He feels the keys to his productivity are his organizational skills when it comes to time management, calendaring and prioritization.
Dr. Rocklage, Ph.D. has over thirty years of experience in healthcare management. He earned his Bachelors of Science degree in Chemistry from the University of California Berkley and then later graduated from Massachusetts Institute of Technology with his PhD in Chemistry.
He joined 5AM Ventures in 2003 as a venture partner and became managing partner in 2004.
5AM Ventures provides support for organizations that are using innovative technology in science and medicine to develop healthcare solutions to assist in the diagnosis, prevention and treatment of a wide variety of medical conditions.
Dr. Rocklage has an impressive resume to say the least. He has served as chief executive officer for multiple corporations. He has experience in healthcare management. Dr. Rocklage has participated in the invention of over 30 U.S. Patents and the author of over 100 publications. He has earned FDA approval of three U.S. New Drug Applications for Omniscan, Teslascan and Cubicin. Rocklage on LinkedIn.
He has served as a board member for many corporations, including as Chariman and CEO of Cubist Pharmaceuticals, President and CEO of Nycomed Salutar, and Board Chairman of Relypsa. He is is currently serving as Chairman for Novira Therapeutics, Inc. and Cidara Theraputics, Inc. He is also the Director of the Board for Rennovia, Inc. To know more click here.